Linsitinib, 99.90%
cas: 867160-71-2 — see every product listed under this CAS number, including other names
Linsitinib, 99.90% (CAS 867160-71-2) is a chemical reagent available from Chemat. Available pack sizes: 5 mg, 10 mg, 100 mg, 10mM/1mL, 25 mg, 50 mg. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-10191-5 mg |
| cas | 867160-71-2 |
| size | 5 mg |
| availability | Get quote |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 5 mg | 435.79 Pln | |
| MedChemExpress | 10 mg | 561.18 Pln | |
| MedChemExpress | 100 mg | 1480.69 Pln | |
| MedChemExpress | 10mM/1mL | 468.30 Pln | |
| MedChemExpress | 25 mg | 825.89 Pln | |
| MedChemExpress | 50 mg | 1104.53 Pln |
properties
| delivery time | over 3 weeks |
|---|---|
| purity | 99.90% |
Linsitinib is an imidazopyrazine that is imidazo[1,5-a]pyrazine substituted by 2-phenylquinolin-7-yl, cis-3-hydroxy-3-methylcyclobutyl, and amino groups at positions 1, 3, and 8, respectively. It is dual inhibitor of the IGF-1 receptor and insulin receptor (IC50 = 35 and 75 nM, respectively) that was previously in clinical development for the treatment of cancer and thyroid eye disease. It has a role as an antineoplastic agent, an antimycobacterial drug, an apoptosis inducer and an insulin-like growth factor receptor 1 antagonist. It is a member of cyclobutanes, a member of benzenes, a member of quinolines, a tertiary alcohol, an aromatic amine and an imidazopyrazine.
Source: ChEBI
| Molecular formula | C26H23N5O |
|---|---|
| Molecular weight | 421.5 g/mol |
| IUPAC name | 3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol |
| InChIKey | PKCDDUHJAFVJJB-UHFFFAOYSA-N |
| SMILES | CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O |
Computed by PubChem (NCBI)